Literature DB >> 17698565

Expression and function of mixed lineage kinases in dendritic cells.

Matthew E Handley1, Jane Rasaiyaah, James Barnett, Manish Thakker, Gabriele Pollara, David R Katz, Benjamin M Chain.   

Abstract

Dendritic cells (DCs) sense the presence of conserved microbial structures in their local microenvironment via specific pattern recognition receptors (PRRs). This leads to a programme of changes, which include migration and activation, and enables them to induce adaptive T cell immunity. Mitogen-activated protein kinases (MAPKs) are implicated in this response, but the pathways leading from PRR ligation to MAPK activation, and hence DC activation, are not fully understood. Recent studies in the nervous system have suggested that the mixed lineage kinase (MLK) family of MAPK kinase kinase proteins may be involved as an intermediary step between PRRs and MAPKs. Therefore, in this study, we have used a well-established DC model to explore the role of MLKs in these cells. Messenger RNA for MLKs 2, 3, 4 and DLK and protein for MLKs 2, 3 and DLK are found in DC. DC activation in response to model PRR ligands, such as LPS or poly (I:C), is accompanied by phosphorylation of MLK3. In contrast, another known PRR ligand, zymosan, induces little MLK3 phosphorylation. Inhibition of MLK activity using a pharmacological inhibitor, CEP11004, blocks p38 and Jun N-terminal kinase (JNK) MAPK activation in response to LPS and poly (I:C), but not zymosan. The inhibition is associated with a block in DC activation as measured by cell-surface marker expression and cytokine secretion. Thus, MLKs are expressed in DC, and are implicated in DC activation, and the involvement of MLKs appears to be selective, depending on the nature of the DC stimulus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698565     DOI: 10.1093/intimm/dxm050

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

Review 1.  Neuropharmacologic Approaches to Restore the Brain's Microenvironment.

Authors:  Weizhe Li; Hsin-I Tong; Santhi Gorantla; Larisa Y Poluektova; Howard E Gendelman; Yuanan Lu
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

2.  Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells.

Authors:  Emily A Desmet; Joseph A Hollenbaugh; Patricia J Sime; Terry W Wright; David J Topham; Andrea J Sant; Toru Takimoto; Stephen Dewhurst; Sanjay B Maggirwar
Journal:  Virology       Date:  2010-02-25       Impact factor: 3.616

Review 3.  Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase.

Authors:  Harris A Gelbard; Stephen Dewhurst; Sanjay B Maggirwar; Michelle Kiebala; Oksana Polesskaya; Howard E Gendelman
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

4.  Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.

Authors:  Val S Goodfellow; Colin J Loweth; Satheesh B Ravula; Torsten Wiemann; Thong Nguyen; Yang Xu; Daniel E Todd; David Sheppard; Scott Pollack; Oksana Polesskaya; Daniel F Marker; Stephen Dewhurst; Harris A Gelbard
Journal:  J Med Chem       Date:  2013-10-03       Impact factor: 7.446

5.  Transcriptional and functional defects of dendritic cells derived from the MUTZ-3 leukaemia line.

Authors:  Jane Rasaiyaah; Mahdad Noursadeghi; Paul Kellam; Benjamin Chain
Journal:  Immunology       Date:  2009-07       Impact factor: 7.397

6.  Mixed lineage kinase phosphorylates transcription factor E47 and inhibits TrkB expression to link neuronal death and survival pathways.

Authors:  Neus Pedraza; Marta Rafel; Isis Navarro; Mario Encinas; Martí Aldea; Carme Gallego
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

Review 7.  Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.

Authors:  Howard E Gendelman; Harris A Gelbard
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

8.  Myeloid Mixed Lineage Kinase 3 Contributes to Chronic Ethanol-Induced Inflammation and Hepatocyte Injury in Mice.

Authors:  Rebecca L McCullough; Paramananda Saikia; Katherine A Pollard; Megan R McMullen; Laura E Nagy; Sanjoy Roychowdhury
Journal:  Gene Expr       Date:  2016-06-09

Review 9.  The regulatory function of mixed lineage kinase 3 in tumor and host immunity.

Authors:  Sandeep Kumar; Sunil Kumar Singh; Basabi Rana; Ajay Rana
Journal:  Pharmacol Ther       Date:  2020-10-09       Impact factor: 13.400

10.  Cloning and Initial Functional Characterization of Mlk4α and Mlk4β.

Authors:  Vladimir I Kashuba; Elvira V Grigorieva; Sergei M Kvasha; Tatiana V Pavlova; Vladimir Grigoriev; Alexei Protopopov; Olga Kharchenko; Rinat Gizatullin; Alla V Rynditch; Eugene R Zabarovsky
Journal:  Genomics Insights       Date:  2011-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.